Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COMMON STOCK, $0.0001 PAR VALUE PER SHARE
-
Shares outstanding
-
5.09M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
337K
-
Shares change
-
-198K
-
Total reported value, excl. options
-
$177K
-
Value change
-
-$556K
-
Number of buys
-
5
-
Number of sells
-
-9
-
Price
-
$0.51
Significant Holders of Matinas BioPharma Holdings, Inc. - COMMON STOCK, $0.0001 PAR VALUE PER SHARE (MTNB) as of Q4 2024
20 filings reported holding MTNB - Matinas BioPharma Holdings, Inc. - COMMON STOCK, $0.0001 PAR VALUE PER SHARE as of Q4 2024.
Matinas BioPharma Holdings, Inc. - COMMON STOCK, $0.0001 PAR VALUE PER SHARE (MTNB) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 337K shares
of 5.09M outstanding shares and own 6.62% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (106K shares), Sargent Investment Group, LLC (64.2K shares), BlackRock, Inc. (49.7K shares), GEODE CAPITAL MANAGEMENT, LLC (43.5K shares), Holos Integrated Wealth LLC (32.5K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (23.8K shares), RENAISSANCE TECHNOLOGIES LLC (18.2K shares), STATE STREET CORP (15.3K shares), UBS Group AG (12.3K shares), and Tower Research Capital LLC (TRC) (1.1K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.